Compugen Regains Compliance with Nasdaq Minimum Bid Price Re

HOLON, Israel, Jan. 8, 2024 /PRNewswire/ -- Compugen Ltd. a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced today that on January 4, 2024,...

Related Keywords

Israel , San Francisco , California , United States , Tel Aviv , Yvonne Naughton , Compugen , Nasdaq Stock Market , Stock Exchange , Astrazeneca , Listing Qualifications Department , Corporate Communications , Prnewswire Compugen Ltd , Compugen Ltd , Nasdaq , Nasdaq Listing Rule , Bid Price , Minimum Bid Price , Minimum Bid Price Requirement , Notification Letter , Investor Relations , Markets ,